Kevin McCulloch bought Xeris Biopharma Holdings ($XERS) shares once on the open market in the last year for $109,475, most recently on June 13, 2025. This ranks 2,062nd among nearly 5,000 insiders, well below the $1.5 million average. He sold shares once for $120,000, latest on January 8, 2026, placing 9,312th out of over 11,000 insiders versus the $8.6 million average.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | M | Common Stock | 48894 | $4.09 | 1,802,721.0000 | 177,617,307 | 2.79% | 0.03% |
| March 12, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | M | Common Stock | 4 | $3.94 | 1,802,725.0000 | 177,617,307 | 0.00% | 0.00% |
| March 12, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | M | Stock Option (Right to Buy) | 48894 | $4.09 | 43,773.0000 | 177,617,307 | 52.76% | 0.03% |
| March 12, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | M | Stock Option (Right to Buy) | 4 | $3.94 | 79,996.0000 | 177,617,307 | 0.01% | 0.00% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Stock Option (Right to Buy) | 225225 | $0.00 | 225,225.0000 | 177,617,307 | 9999.99% | 0.13% |
| Jan. 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Common Stock | 168463 | $0.00 | 1,878,889.0000 | 177,617,307 | 9.85% | 0.09% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 68454 | $7.36 | 1,810,435.0000 | 177,617,307 | 3.64% | 0.04% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 30289 | $7.36 | 1,780,146.0000 | 177,617,307 | 1.67% | 0.02% |
| Jan. 31, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 27319 | $7.36 | 1,752,827.0000 | 177,617,307 | 1.53% | 0.02% |
| Jan. 8, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | S | Common Stock | 15000 | $8.00 | 1,710,426.0000 | 177,617,307 | 0.87% | 0.01% |
| Oct. 2, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 733 | $8.31 | 1,725,426.0000 | 177,617,307 | 0.04% | 0.00% |
| Sept. 11, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | J | Common Stock | 2000 | $0.00 | 1,726,159.0000 | 146,772,758 | 0.12% | 0.00% |
| Aug. 1, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 14651 | $5.38 | 1,728,159.0000 | 146,772,758 | 0.84% | 0.01% |
| June 13, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | P | Common Stock | 25000 | $4.38 | 1,735,585.0000 | 146,772,758 | 1.46% | 0.02% |
| April 2, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 733 | $5.15 | 1,710,585.0000 | 146,772,758 | 0.04% | 0.00% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 48834 | $3.56 | 1,526,318.0000 | 146,772,758 | 3.10% | 0.03% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Stock Appreciation Right | 500000 | $0.00 | 500,000.0000 | 146,772,758 | 9999.99% | 0.34% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 29300 | $3.56 | 1,575,152.0000 | 146,772,758 | 1.83% | 0.02% |
| Jan. 31, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Common Stock | 185000 | $0.00 | 1,711,318.0000 | 146,772,758 | 12.12% | 0.13% |
| Jan. 3, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | F | Common Stock | 24501 | $3.61 | 1,604,452.0000 | 146,772,758 | 1.50% | 0.02% |
| Aug. 1, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Stock Appreciation Right | 200000 | $0.00 | 200,000.0000 | 137,674,857 | 9999.99% | 0.15% |
| Aug. 1, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | McCulloch Kevin | See Remarks | A | Common Stock | 150000 | $0.00 | 1,601,953.0000 | 137,674,857 | 10.33% | 0.11% |